Telomir Pharmaceuticals, Inc. Common Stock (TELO)
NASDAQ·Healthcare·Biotechnology
$1.47
+3.17%
Mkt Cap $45.04M
No analyst coverage available
We don't have analyst ratings or price target data for Telomir Pharmaceuticals, Inc. Common Stock yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.